VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Net income, 2025
- $4.0B
- 5-year CAGR
- +7.8%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $4.0B | — |
| 2024 | −$536M | — |
| 2023 | $3.6B | +9.0% |
| 2022 | $3.3B | +41.8% |
| 2021 | $2.3B | −13.6% |
| 2020 | $2.7B | +130.4% |
| 2019 | $1.2B | −43.9% |
| 2018 | $2.1B | +695.8% |
| 2017 | $263M | — |
| 2016 | −$112M | — |
| 2015 | −$556M | — |
| 2014 | −$739M | — |
| 2013 | −$445M | — |
| 2012 | −$107M | — |
| 2011 | $30M | — |
| 2010 | −$755M | — |
| 2009 | −$642M | — |
| 2008 | −$460M | — |